Perfil
Denis G.
Kay is the founder of Alpha Cognition, Inc., founded in 2000, serving as Chief Scientific Officer.
Dr. Kay is the founder of Neurodyn Life Sciences, Inc., founded in 2006, serving as Chief Scientific Officer.
Former job includes Director & Chief Scientific Officer at Neurodyn, Inc. Education includes a doctorate from McGill University and undergraduate and graduate degrees from Dalhousie University.
Cargos activos de Denis Kay
| Empresas | Cargo | Inicio |
|---|---|---|
| ALPHA COGNITION INC. | Fundador | 01/01/2000 |
Neurodyn Life Sciences, Inc.
Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases | Fundador | 01/08/2006 |
Antiguos cargos conocidos de Denis Kay.
| Empresas | Cargo | Fin |
|---|---|---|
Neurodyn, Inc.
Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection | Director Técnico/Científico/I+D | - |
Formación de Denis Kay.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dalhousie University
Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurodyn, Inc.
Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection | Health Technology |
Neurodyn Life Sciences, Inc.
Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
- Bolsa de valores
- Insiders
- Denis Kay
















